GWELLIA Trademark

Trademark Overview

On Friday, June 4, 2021, a trademark application was filed for GWELLIA with the United States Patent and Trademark Office. The USPTO has given the GWELLIA trademark a serial number of 90755016. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, July 16, 2024. This trademark is owned by vTv Therapeutics LLC. The GWELLIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, namely anti-diabetic drugs
gwellia

General Information

Serial Number90755016
Word MarkGWELLIA
Filing DateFriday, June 4, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, July 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use, namely anti-diabetic drugs
Translation of Words in MarkThe wording GWELLIA has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamevTv Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHigh Point, NC 27265
Party NamevTv Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHigh Point, NC 27265

Trademark Events

Event DateEvent Description
Thursday, August 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 8, 2021NEW APPLICATION ENTERED
Tuesday, February 22, 2022ASSIGNED TO EXAMINER
Tuesday, February 22, 2022NON-FINAL ACTION WRITTEN
Tuesday, February 22, 2022NON-FINAL ACTION E-MAILED
Tuesday, February 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 4, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 4, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 4, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 7, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, September 7, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, September 7, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, September 13, 2022TEAS PETITION TO REVIVE RECEIVED
Tuesday, September 13, 2022PETITION TO REVIVE-GRANTED
Tuesday, September 13, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 14, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, September 14, 2022NOTICE OF REVIVAL - E-MAILED
Tuesday, October 18, 2022ATTORNEY REVIEW COMPLETED
Tuesday, October 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 28, 2023SOU EXTENSION 1 FILED
Tuesday, January 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 28, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 28, 2023SOU EXTENSION 1 GRANTED
Tuesday, July 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 16, 2024SOU EXTENSION 3 FILED
Tuesday, July 16, 2024SOU EXTENSION 3 GRANTED
Saturday, January 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 11, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 11, 2024SOU EXTENSION 2 FILED
Thursday, January 11, 2024SOU EXTENSION 2 GRANTED

Related Keywords

gwellia diabetic drugs anti namely preparations human pharmaceutical